Dihydropyrimidine dehydrogenase (DPD), the initial, ratelimiting step in pyrimidine degradation, was studied in two cell lines of murine neuroblastoma (MNB-T1 and MNB-T2) that were derived from C-1300 MNB tumor carried in A/J mice. The MNB-T2 (low malignancy) cell line was originally derived from the in situ tumor and carried in tissue culture for more than 100 passages; the MNB-T1 (high malignancy) line consisted of a new sub-culture that was also established from the in situ MNB tumor. DPD activity was determined in cytosolic preparations of MNB utilizing high performance liquid chromatography to separate the radiolabeled substrate (12-'4Cjthy-mine) from [2-'4Cjdihydrothymine. The apparent affinity of DPD for NADPH in MNB cells (Km -0.08 mM) was identical to that of A/J mouse brain and liver. The DPD activity of the high malignancy (MNB-T1) cell line was 14.3% of that observed in the low malignancy (MNB-T2) line. In situ tumors formed after implantation of high malignancy (MNB-T1) cells into A/J mice had only 25.2% of the DPD activity observed in tumors derived from low malignancy (MNB-T2) cells. When MNB-T2 cells were injected into naive A/J mice, tumors developed in only 68% of animals, the tumor growth rate was slow and a mortality of 20% was observed. In contrast, tumors derived from injected MNB-T1 cells showed a faster growth rate and 100% mortality. Most MNB-T2 derived tumors were not lethal and ultimately resolved while the MNB-T1 derived tumors were invariably lethal. These studies support the concept that the levels of DPD activity in neoplastic cells are inversely related to their malignant expression and also provide a model to study differences between neuroblastoma cell lines derived from the same in situ tumor but which manifest different neoplastic behavior.
Introduction
The investigation of the pyrimidine degradation pathways ( Fig. 1 ) in neoplastic tissues is important because these enzymes may critically regulate the concentration of pyrimidine bases required for DNA and RNA synthesis during cellular proliferation (1) . Furthermore, this degradative pathway is also responsible for the catabolism oftherapeutically useful pyrimi-dine base analogues such as 5-fluorouracil, 5-bromouracil, 5-diazouracil, 5-iodouracil, and 5-nitrouracil (2) .
The extent of pyrimidine base degradation in hepatoma cells has been extensively studied by Weber et al. (3) who proposd the "molecular correlation concept" theory to explain the inverse relationship between increased pyrimidine "salvage" activity and decreased pyrimidine degradative activity observed in hepatoma cells when compared with normal liver. However, Naguib et al. (4) using modified dihydropyrimidine dehydrogenase (DPD)' assays that were more sensitive and specific than those utilized in the previous study (3) , reported that some solid tumors displayed higher activity of pyrimidine degradative enzymes than their nonneoplastic counterparts. This observation suggested that DPD might also act as an anabolic enzyme in some tumor tissues by catalyzing pyrimidine synthesis.
The mechanisms regulating pyrimidine degradation in normal or neoplastic cells remain poorly understood. Although various nucleotides, nucleosides, and bases can modify the activity of DPD in vitro (5) it is unclear whether these factors affect pyrimidine degradative enzymes in vivo. For example, DPD is inactive in the absence of its cofactor NADPH; thus, it is possible that the affinity of this enzyme for NADPH and/or the availability of this cofactor may determine the rate of pyrimidine degradation in vivo.
This investigation has examined the changes in DPD activity and its dependence on NADPH in C-1300 murine neuroblastoma cells (MNB), obtained from tissue culture and from in situ tumors. A new, sensitive and highly specific assay for DPD, which is based on the separation of radiolabeled substrate and its metabolite by HPLC was used. In situ growth ofMNB-TI and MNB-T2 cells. Two groups of male A/J mice consisting of 25 animals each, were injected subcutaneously with 106 cells harvested from MNB-TI or MNB-T2 tissue cultures.
Mice were examined daily for tumor growth by measuring the length and width of each tumor. 14 d after MNB implantation five mice with palpable tumors were killed from each group. MNB tumors were excised and DPD activity and catecholamine concentration determined. The remaining mice were examined daily either until death or spontaneous resolution of the tumors.
Preparation of enzyme supernatants. Cytosolic preparations of liver, brain, tumor tissue and cultured MNB cells were obtained by ultracentrifugation at 105,000 g for 1 h at 4°C. The supernatant fluid was carefully decanted (to avoid the lipid layer) and protein concentration determined by the Lowry method (6). Enzyme activity was generally assayed on the day of tissue harvest; however, enzyme activity remained stable for 1 wk at 4°C and for several months at -80°C.
Assay of enzyme activity. Palo Alto, CA) with a photodiode array detector, DPU integration package and 85B microcomputer as the system controller. Separation was by reverse-phase chromatography using a Cl8 analytical cartridge column (4.6 X 150 mm; 3 Mm particles) and equipped with a 4.6 X 10 mm guard cartridge (Econosphere; Alltech Associates, Inc., Deerfield, IL). The mobile phase was 0.02 M monobasic phosphate (Ultrex grade; J.T. Baker Chemical Co., Phillipsburg, NJ), pH 5.6 with an acetonitrile gradient of 0.2%/min for the first 5 min and 0.8%/min for the next 5 min to a final concentration of 5%. The flow rate was 0.75 ml/min. Standard solutions of thymine, dihydrothymine, and ureidoisobutyrate in distilled H20 were injected to determine the retention times of all compounds. A typical chromatographic separation profile is shown in Fig. 2 . Thymine, which possesses a double bond, has a characteristic 2. In the initial phase of this study 200M,M NADPH was employed in the DPD reaction mixture that also contained 5 mM 2ME. Under those conditions, that had been considered optimal for the assay of DPD in rat liver supernatant (7) , little DPD activity was detected (-20 pmol/mg protein per h) in cytosol prepared from cultured MNB cells (MNB-T2). DPD activity in the MNB cells could be easily detected however, if higher concentrations of NADPH were employed. The requirement of higher NADPH concentrations was found to be related to the presence of 2ME in phosphate buffer when it was stored for longer than a few days. The absence of 2ME in the stored buffer or, alternatively, addition of fresh 2ME directly to an inactive reaction mixture resulted in the marked restoration of DPD activity even in the presence of low NADPH concentrations (0.05 mM). However, at NADPH concentrations of greater than 2.5 mM, maximal DPD activity (Vm,,,) observed was independent of2ME concentration (see Fig. 4 ). Time (min) Figure 3 . Reconstruction of the chromatographic separation of radiolabeled dihydrothymine and thymine. Radioactive (14C) fractions of 0.04 min duration were collected from an experimental sample and the radioactivity determined as described in Methods.
ultraviolet spectrum with peak absorption maxima at 205 and 254 nm, whereas dihydrothymine and ureidoisobutyrate show an absorption maximum only at 205 nm. As demonstrated in Fig. 2 , the difference in retention times between thymine and dihydrothymine was very short (0.3 min). Therefore, it was necessary to collect small fractions (0.04 min; 30 Ml) to facilitate the uncontaminated separation of labeled thymine and its dihydrothymine metabolite (Fig. 3) . The substrate and product peaks were collected directly into scintillation vials containing 3.5 ml scintillation fluid (Safety-Solv; Research Products International, Mt. Prospect, IL) using a fraction collector (FRAC 100 Pharmacia; Pharmacia Fine Chemicals, Piscataway, NJ). The activity of ureidopropionase (UP) was assayed by determining the quantity of '4C02 released during the reaction. The 14C present in the collected fractions and in the hyamine hydroxide-soaked filters was counted by a liquid scintillation counter (LS 7500; Beckman Instruments, Inc., Fullerton, CA). The specific activity of each enzyme was calculated from the amount of product formed and expressed as picomoles per milligram protein per hour. The lower limit of detection of DPD activity with this method was 15 pmol/mg per h. Tissue catecholamines. Determinations of norepinephrine, epinephrine, and dopamine content in MNB-Tl and MNB-T2 tumors was performed by HPLC coupled to an electrochemical detector as previously described (8) .
Results
Activity ofpyrimidine degrading enzymes in liver, brain, and murine neuroblastoma. Fig. 4 illustrates the relationship between the concentration ofNADPH and the specific activity of DPD in the presence and absence of 2ME. Table II . The specific activity of DPD in tumors derived from injected MNB-T 1 cells was similar to that found in the parent MNB-T 1 cultured cell line. This activity was significantly lower than that of MNB-T2 cells and tumors derived from this line (P < 0.001). Tumors derived from the MNB-Tl cell line contained less norepinephrine and dopamine than tumors derived from the MNB-T2, but the differences were not statistically significant (P > 0.05). Trace amounts of epinephrine were detected in both tumor types. 32% of the mice injected with MNB-T2 cells did not develop tumors and those that did showed a significantly slower tumor growth rate (Fig. 5 ) and reduced mortality (Fig. 6 ) when compared to mice implanted with MNB-T1 cells.
Discussion
The relationship between pyrimidine base metabolism by dihydropyrimidine dehydrogenase (E.C. 1.3.1.2) and neoplastic expression in MNB cells has been investigated. This investiga- A variety of analytical methods have been employed to measure pyrimidine base degradative enzyme activity in tissues. The spectrophotometric methods for DPD is adequate for tissues with high enzymatic activity, but not sensitive enough for tissues with low enzymatic activities. The utiliza-80% suMval tion of radiolabeled substrates coupled to the separation of substrate and products by TLC is considerably more sensitive (18) , however this chromatographic technique is much less efficient than HPLC. In this investigation, we have used radiolabeled thymine as the substrate, as opposed to radiolabeled uracil which was previously employed in the TLC method. Thymine is less polar, and hence retained longer on reverse phase chromatographic columns, thus, improving the separation of the substrate from its product (Fig. 2) human tissues with low enzymatic activity.
In conclusion, our results suggest that the MNB cell system provides a useful model for further investigation of the control mechanisms regulating pyrimidine degradative activity in cancer cells.
